Vaughan & Co Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$822K Sell
7,948
-436
-5% -$38.9K 0.38% 25
2026
Q1
$602K Sell
8,384
-344
-4% -$26.5K 0.31% 40
2025
Q4
$693K Sell
8,728
-378
-4% -$29.8K 0.36% 29
2025
Q3
$687K Sell
9,106
-4,165
-31% -$285K 0.36% 34
2025
Q2
$915K Hold
13,271
0.53% 19
2025
Q1
$899K Buy
+13,271
New +$794K 0.56% 19

Other funds holding CVS

Vaughan & Co Securities's CVS Position: Q2 2026 in Review

Vaughan & Co Securities reduced its CVS Health (CVS) stake by 5.2% in Q2 2026, selling an estimated $38.9K and leaving 7,948 shares worth $822K. The position accounts for 0.38% of the portfolio, ranked #25.

Vaughan & Co Securities first reported a position in CVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $915K in Q2 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Vaughan & Co Securities held 7,948 shares of CVS Health worth $822K as of Q2 2026.
  • Vaughan & Co Securities sold 436 CVS Health shares in Q2 2026, an estimated $38.9K.
  • CVS Health made up 0.38% of Vaughan & Co Securities's portfolio in Q2 2026, its #25 holding.
  • Vaughan & Co Securities first reported a position in CVS Health in Q1 2025 and has held it in 6 quarters since.
  • Vaughan & Co Securities's CVS Health position peaked at $915K in Q2 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Vaughan & Co Securities's 13F filing for Q2 2026, filed 3 Aug 2026.